Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Broken Hip

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    22 result(s) found for: Broken Hip. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2022-003163-21 Sponsor Protocol Number: COTHUGMTRA22 Start Date*: 2023-07-13
    Sponsor Name:Coral Sánchez Pérez
    Full Title: PHASE III, SINGLE-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, LOW-INTERVENTION CLINICAL TRIAL IN TWO PARALLEL GROUPS, TO EVALUATE EFFICACY AND SAFETY IN ELDERLY PATIENTS WITH PERTROCHANTE...
    Medical condition: pertrochanteric hip fracture
    Disease: Version SOC Term Classification Code Term Level
    23.0 10022117 - Injury, poisoning and procedural complications 10020100 Hip fracture PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-000654-38 Sponsor Protocol Number: AHUS2015-000654-38 Start Date*: 2015-10-19
    Sponsor Name:Akershus University Hospital, Norway
    Full Title: Secondary prophylaxis after hip fracture. An evaluation og two organisational models based on choise of treatment: a comparison of efficacy and applicability of hospital based treatment with zoled...
    Medical condition: Hip fracture
    Disease: Version SOC Term Classification Code Term Level
    17.1 10022117 - Injury, poisoning and procedural complications 10020100 Hip fracture PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: NO (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2020-002143-27 Sponsor Protocol Number: 73950 Start Date*: 2021-02-09
    Sponsor Name:Maasstad Ziekenhuis
    Full Title: Spinal morphine in patients with hip fractures to reduce delirium
    Medical condition: Proximal femur fracture
    Disease: Version SOC Term Classification Code Term Level
    20.0 10028395 - Musculoskeletal and connective tissue disorders 10017322 Fractures HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-017153-35 Sponsor Protocol Number: ALMED-08-C2-020 Start Date*: 2010-04-06
    Sponsor Name:AIR LIQUIDE SANTE INTERNATIONAL
    Full Title: An international, multi-center, randomized, controlled trial evaluating the effect of xenon on post-operative delirium in elderly patients undergoing hip fracture surgery.
    Medical condition: Post-operative delirium after hip fracture surgery under general anaesthesia
    Disease: Version SOC Term Classification Code Term Level
    12.1 10020100 Hip fracture LLT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: FR (Completed) DE (Completed) GB (Completed) ES (Completed) IT (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2020-004697-21 Sponsor Protocol Number: PENG-CAD Start Date*: 2020-12-11
    Sponsor Name:Instituto de Investigación Biomédica de Salamanca
    Full Title: RANDOMIZED AND CONTROLLED PHASE IV CLINICAL TRIAL ON THE ANALGESIC EFFECTIVENESS OF THE COMBINED BLOCKADE (PENG -PERICAPSULAR NERVE GROUP- AND THE FEMORAL LATERAL CUTANEOUS NERVE) IN THE HIP FRACTU...
    Medical condition: Most appropriate anesthetic technique for surgery of hip fracture in the elderly
    Disease: Version SOC Term Classification Code Term Level
    23.0 10022117 - Injury, poisoning and procedural complications 10020100 Hip fracture PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2016-002354-20 Sponsor Protocol Number: VIK_001 Start Date*: 2016-09-14
    Sponsor Name:DOTT.SSA CARMELINDA RUGGIERO,ISTITUTO DI GERIATRIA E GERONTOLOGIA, UNIVERSITà DEGLI STUDI DI PERUGIA
    Full Title: EFFECTIVNESS OF WARFARIN REVERSAL USING INTRAVENOUS VITAMIN K AMONG HIP FRACTURE OLDER PERSONS: A RANDOMIZED CLINICAL TRIAL
    Medical condition: Hip fractured subjects on warfarin therapy
    Disease: Version SOC Term Classification Code Term Level
    23.0 10022117 - Injury, poisoning and procedural complications 10020100 Hip fracture PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-003850-10 Sponsor Protocol Number: Laxatives26.09.2019 Start Date*: 2020-02-10
    Sponsor Name:Hospital Pharmacy Funen, Research Department, Odense University Hospital
    Full Title: Oral laxatives after hip fracture surgery: A randomised controlled trial.
    Medical condition: The aim is to investigate which constipation therapy is the most optimal choice for postoperative treatment in older patients after hip fracture surgery compared to placebo.
    Disease: Version SOC Term Classification Code Term Level
    23.0 10022117 - Injury, poisoning and procedural complications 10020100 Hip fracture PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: DK (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-001832-34 Sponsor Protocol Number: 3100N7-211-WW Start Date*: 2007-01-11
    Sponsor Name:Wyeth Pharmaceuticals Inc.
    Full Title: A Phase 2, Multicenter, Single-Blind, Randomized, Stratified, Standard-of-Care Controlled, Feasibility and Safety Study of rhBMP-2/CPM as an Adjuvant Therapy for Fractures of the Proximal Femur
    Medical condition: Closed fracture of the proximal femur
    Disease: Version SOC Term Classification Code Term Level
    8.1 10020100 Hip fracture LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) FI (Completed) HU (Completed) FR (Completed) SE (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-023871-25 Sponsor Protocol Number: 2010-023871-25 Start Date*: 2011-04-20
    Sponsor Name:Nottingham University Hospitals NHS Trust
    Full Title: The FINOF(Femoral Nerve-Block Intervention in Neck Of Femur Fracture) Study
    Medical condition: Pain and mobility following hip fracture in the elderly
    Disease: Version SOC Term Classification Code Term Level
    13.1 10042613 - Surgical and medical procedures 10036236 Postoperative pain relief LLT
    13.1 10022117 - Injury, poisoning and procedural complications 10054711 Postoperative pain LLT
    13.1 10022117 - Injury, poisoning and procedural complications 10020100 Hip fracture PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-015865-30 Sponsor Protocol Number: PAHFRAC-01 Start Date*: 2010-06-24
    Sponsor Name:Máximo Bernabeu Wittel
    Full Title: ENSAYO CLINICO RANDOMIZADO DOBLE CIEGO DE HIERRO CARBOXIMALTOSA INTRAVENOSO CON O SIN ERITOPOYETINA PARA LA PREVENCIÓN DE TRANSFUSIONES DE CONCENTRADOS DE HEMATÍES EN EL PERIOPERATORIO DE FRACTURA ...
    Medical condition: Pacientes adultos ingresados en el Hospital por fractura de cadera osteoporótica. Adult patients admitted in Hospital for osteoporotic hip fracture
    Disease: Version SOC Term Classification Code Term Level
    11 10020100 Fractura de cadera LLT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-022816-38 Sponsor Protocol Number: 2010-09-20 Start Date*: 2010-12-22
    Sponsor Name:Department of Anesthesiology & Intensive Care
    Full Title: Preoperative Optimization of the High-Risk Patient undergoing Hip Fracture Surgery
    Medical condition: Patients with elevated NT-proBNP as a sign of left ventricular dysfunction undergoing hipfracturesurgery.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10020100 Hip fracture PT
    12.1 10019283 Heart failure signs and symptoms HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-001543-13 Sponsor Protocol Number: HIP-SAP Start Date*: 2018-03-28
    Sponsor Name:Morten Tange Kristensen/Hvidovre Hospital
    Full Title: Preliminary effect and safety of physiotherapy with strength training and protein-dense nutritional supplement in combination with anabolic steroids in cross-continuum rehabilitation of patients wi...
    Medical condition: Area of investigation is recovery of muscle strength and function following hip fracture surgery.
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004863 10017287 Fractured hip LLT
    20.1 100000004863 10017299 Fractured neck of femur LLT
    20.1 100000004863 10034736 Pertrochanteric fracture of femur, closed LLT
    20.1 100000004863 10053653 Femur fracture subtrochanteric LLT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2017-003875-77 Sponsor Protocol Number: 1870 Start Date*: 2018-01-24
    Sponsor Name:University Hospitals of North Midlands NHS Trust
    Full Title: A Randomised, Controlled Double Blinded Non-inferiority Trial of intravenous Morphine compared with intravenous Paracetamol for pain relief in patients presenting to the Emergency Department with S...
    Medical condition: Fractured Neck of Femur
    Disease: Version SOC Term Classification Code Term Level
    20.0 10022117 - Injury, poisoning and procedural complications 10020100 Hip fracture PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-001048-32 Sponsor Protocol Number: 0701017 Start Date*: 2008-09-15
    Sponsor Name:CHU SAINT-ETIENNE
    Full Title: Prospective, multicentre, open-label study evaluating Fondaparinux (1,5 mg/day) in venous thromboembolic events prevention in patients with renal impairment defined by a creatinin clearance between...
    Medical condition: Patients with renal impairment defined by a creatinin clearance between 20 and 50 ml/min and undergoing a major orthopaedic surgery (hip fracture, total hip replacement and total knee replacement)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038474 Renal insufficiency LLT
    9.1 10020100 Hip fracture LLT
    9.1 10023476 Knee osteoarthritis LLT
    9.1 10049909 Venous thromboembolism prophylaxis LLT
    9.1 10020108 Hips osteoarthritis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-003439-31 Sponsor Protocol Number: CBYM338D2201 Start Date*: 2014-06-17
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A 24-week Double-blind Treatment and 24-week Follow-up, Randomized, Multicenter, Placebo-controlled, Phase IIa/IIb Study to Evaluate Safety and Efficacy of i.v. Bimagrumab on Total Lean Body Mass a...
    Medical condition: Patients with muscle wasting (atrophy) after hip fracture surgery and subsequent postsurgical rehabilitation
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004859 10028371 Muscular wasting and disuse atrophy, not elsewhere classified LLT
    20.0 10022117 - Injury, poisoning and procedural complications 10020100 Hip fracture PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: BE (Completed) GB (Completed) DE (Completed) HU (Completed) CZ (Completed) AT (Completed)
    Trial results: View results
    EudraCT Number: 2016-000377-20 Sponsor Protocol Number: VK5211-201 Start Date*: 2016-05-27
    Sponsor Name:Viking Therapeutics, Inc.
    Full Title: A Phase II, Randomized, Double-Blind, Parallel Group, Placebo- Controlled, Multi-Center Study to Explore the Efficacy, Safety and Tolerability of VK5211 in Subjects with Acute Hip Fracture
    Medical condition: Hip fracture
    Disease: Version SOC Term Classification Code Term Level
    19.0 10022117 - Injury, poisoning and procedural complications 10020100 Hip fracture PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-001923-53 Sponsor Protocol Number: 7980 Start Date*: 2015-10-07
    Sponsor Name:Rafael Bielza Galindo
    Full Title: Intravenous iron, early functional recovery and delirium in patients atients with hip fracture
    Medical condition: Hip fracture
    Disease: Version SOC Term Classification Code Term Level
    18.0 10022117 - Injury, poisoning and procedural complications 10020100 Hip fracture PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-003233-34 Sponsor Protocol Number: 11048 Start Date*: 2012-01-19
    Sponsor Name:University of Nottingham
    Full Title: The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients – a pilot study
    Medical condition: Anaemia following hip fracture
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-013462-25 Sponsor Protocol Number: MW001 Start Date*: 2009-09-28
    Sponsor Name:NHS Greater Glasgow and Clyde Health Board
    Full Title: A dose finding study for ultrasound guided anterior psoas compartment blocks in patients with a fractured neck of femur
    Medical condition: Proximal traumatic fractured neck of femur
    Disease: Version SOC Term Classification Code Term Level
    10029173 Nerve block LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2016-004698-42 Sponsor Protocol Number: 10102016 Start Date*: 2017-05-29
    Sponsor Name:
    Full Title: MORphine use in the Fascia Iliaca Compartment block with UltraSound guidance.
    Medical condition: Pain in proximal femur fractures
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 20 05:21:33 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA